RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for Aripiprazole:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Aripiprazole is an atypical antipsychotic agent used for the treatment of acute agitation in adults with schizophrenia or bipolar mania, for mood stabilization in patients with bipolar I disorder, as an adjunctive medication for depression, and for treatment of schizophrenia. In children, it as been used for treatment of aggression, conduct disorder, Tourette syndrome, bipolar I disorder, irritability associated with autistic disorder, and schizophrenia.
- PHARMACOLOGY: Aripiprazole is a quinolinone antipsychotic that has moderate to high affinity to various dopaminergic and serotonin receptors as well as H1 and alpha-1 adrenergic receptors. It also has moderate affinity for the serotonin reuptake transporter and acts as a partial agonist at the D2 and 5-HT1a receptors and as an antagonist at the 5-HT2a receptor.
- TOXICOLOGY: Aripiprazole exerts its toxicity through the above effects on the various receptors.
- EPIDEMIOLOGY: Overdose is fairly common; severe toxicity is rare and fatalities have not been reported from overdose with aripiprazole alone.
- WITH THERAPEUTIC USE
- COMMON: The most common adverse reactions include CNS symptoms (headache, agitation, insomnia, anxiety, extrapyramidal symptoms, akathisia, sedation) and gastrointestinal symptoms (weight gain, nausea, constipation, vomiting, dyspepsia).
- LESS FREQUENT: Other rarer adverse effects include other CNS symptoms (dizziness, pyrexia, restlessness, fatigue, lethargy, lightheadedness, pain, dystonia, hypersomnia, irritability, impaired coordination, suicidal ideation), cardiovascular symptoms (orthostatic hypotension, tachycardia, chest pain, hypertension, peripheral edema), dermatologic symptoms (rash, hyperhidrosis), gastrointestinal symptoms (increased salivation, decreased appetite, increased appetite, xerostomia, toothache, abdominal pain, diarrhea, weight gain), neuromuscular and skeletal symptoms (tremor, extremity pain, stiffness, myalgias, spasm, arthralgias, dyskinesia, increased creatine phosphokinase, weakness), and respiratory symptoms (nasopharyngitis, pharyngolaryngeal pain, cough, rhinorrhea).
- WITH POISONING/EXPOSURE
- MILD TO MODERATE TOXICITY: In overdose, the most prominent effect seen is CNS sedation. After a mild to moderate exposure, other symptoms reported have included tachycardia, tremors, irritability, and nausea/vomiting.
- SEVERE TOXICITY: More severe effects reported from aripiprazole overdoses/exposures include hypotension, coma, and neuroleptic malignant syndrome.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.